<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17936" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Ataxia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hafiz</surname>
            <given-names>Sumaiya</given-names>
          </name>
          <aff>Cleveland Clinic Abu Dhabi</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>De Jesus</surname>
            <given-names>Orlando</given-names>
          </name>
          <aff>University of Puerto Rico, Medical Sciences Campus, Neurosurgery Section</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sumaiya Hafiz declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Orlando De Jesus declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>23</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17936.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Ataxia is a neurological sign that manifests in a lack of coordination in the movement of different muscles in the body. It is a clinical finding and not a disease, which mainly presents abnormalities in gait, changes in speech such as scanning speech, and abnormal eye movements such as nystagmus. This activity describes and outlines the evaluation and management of ataxia, and highlights the role of an interprofessional team, in managing and providing for patients with ataxia.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiologies of ataxia.</p></list-item><list-item><p>Review the process of evaluation for ataxia.</p></list-item><list-item><p>Outline management options available for ataxia.</p></list-item><list-item><p>Summarize interprofessional team strategies for improving care coordination and communication in patients with ataxia and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17936&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17936">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-17936.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Ataxia is a neurological sign that manifests in a lack of coordination in the movement of different muscles in the body.<xref ref-type="bibr" rid="article-17936.r1">[1]</xref> It is a clinical finding and not a disease, which mainly presents abnormalities in gait, changes in speech such as scanning&#x000a0;speech, and abnormal eye movements such as nystagmus. It results from dysfunction of the brain areas, responsible for the coordination of movements, and, most commonly, the cerebellum. The three types of ataxia, according to the location, are cerebellar, sensory, and vestibular.</p>
        <p>Ataxia can also subdivide into sporadic (patients have no family history of ataxia and manifest&#x000a0;in adulthood), hereditary (caused by a defect in a gene and manifesting in childhood), and acquired (due to structural or demyelinating conditions, toxicity, paraneoplastic, inflammatory or infections, and autoimmune conditions).<xref ref-type="bibr" rid="article-17936.r2">[2]</xref>&#x000a0;Friedreich ataxia is an autosomal recessive form of ataxia and the commonest among the hereditary forms.</p>
      </sec>
      <sec id="article-17936.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Ataxia may occur due to abnormalities in the nervous system's different areas, including the brain, spinal cord, nerves, and nerve roots.&#x000a0;The different types of ataxia often have similar or overlapping causes in the same patient.<xref ref-type="bibr" rid="article-17936.r3">[3]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Focal lesions - due to tumors, stroke, multiple sclerosis, or inflammation</p>
          </list-item>
          <list-item>
            <p>Metabolic - due to substances such as alcohol, antidepressant drugs, and antiepileptic drugs</p>
          </list-item>
          <list-item>
            <p>Poisoning - due to radiation</p>
          </list-item>
          <list-item>
            <p>Vitamin B12 deficiency</p>
          </list-item>
          <list-item>
            <p>Thyroid disease - hypothyroidism</p>
          </list-item>
          <list-item>
            <p>Head injury</p>
          </list-item>
          <list-item>
            <p>Celiac disease (gluten ataxia)</p>
          </list-item>
          <list-item>
            <p>Hereditary - Friedreich ataxia, ataxia-telangiectasia, Niemann-Pick disease, fragile X associated ataxia/tremor syndrome&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Arnold-Chiari malformation</p>
          </list-item>
          <list-item>
            <p>Wilson disease</p>
          </list-item>
          <list-item>
            <p>Succinic semialdehyde dehydrogenase deficiency</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17936.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The overall prevalence of ataxia is 26 cases per 100,000 in children. The overall prevalence rate of hereditary ataxias is 10 cases per 100,000 individuals.<xref ref-type="bibr" rid="article-17936.r4">[4]</xref>&#x000a0;Dominant cerebellar ataxia is present in 2.7 cases per 100,000 individuals, and recessive hereditary cerebellar ataxia in 3.3 per 100,000 individuals.<xref ref-type="bibr" rid="article-17936.r5">[5]</xref>&#x000a0;An increased prevalence occurs in countries where consanguinity is a common practice.<xref ref-type="bibr" rid="article-17936.r6">[6]</xref>&#x000a0;The worldwide prevalence of spinocerebellar ataxias is 3&#x000a0;to 5.6 cases per 100,000 individuals.<xref ref-type="bibr" rid="article-17936.r7">[7]</xref>&#x000a0;The most common spinocerebellar ataxia is spinocerebellar ataxia type 3.<xref ref-type="bibr" rid="article-17936.r8">[8]</xref></p>
      </sec>
      <sec id="article-17936.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Ataxia may be due to an interference in the sensory transmission to the cerebellum caused by a lesion. This condition can lead to sensory or spinal ataxia. An interruption in cortical signals from the cerebellum causes cerebellar ataxia. Spinocerebellar ataxias are a result of both of the above mentioned pathologies. They are autosomal dominant and result from CAG repetition on chromosomes.</p>
        <p>Friedreich's ataxia is the most common of the inherited ataxias. It has an autosomal recessive pattern of inheritance. It involves the frataxin gene. There is degeneration of peripheral nerve axons and loss of sensory cells. Patients present between the first and second decades of life. Multisystem abnormalities are present and include, gait ataxia, loss in proprioception, sensory loss, pes cavus, spastic extensor plantar responses, atrophy of extremities, and cardiomyopathy. Patients may also have diabetes mellitus, vision loss, and hearing loss.<xref ref-type="bibr" rid="article-17936.r9">[9]</xref><xref ref-type="bibr" rid="article-17936.r10">[10]</xref></p>
        <p>Depending on the location of the lesion, characteristic findings are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Lesions in the lateral cerebellum cause symptoms on the same side as the lesion (ipsilateral), whereas diffuse lesions cause generalized symptoms.</p>
          </list-item>
          <list-item>
            <p>Lesions in the cerebellum hemisphere cause limb ataxia.</p>
          </list-item>
          <list-item>
            <p>Lesions in the vermis cause truncal, gait ataxia with sparing of the limbs.</p>
          </list-item>
          <list-item>
            <p>Lesions at vestibulo-cerebellar areas cause disbalance, vertigo and gait ataxia.<xref ref-type="bibr" rid="article-17936.r11">[11]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17936.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Adequate history and examination are crucial parts in evaluating, assessing the location of the lesion, and treating patients with ataxia. The medical history should include age, gender, neurological, drug, toxin, and occupational exposures. Family history is essential.&#x000a0;Systems review should assess the presence of constitutional symptoms such as fever, weight loss, and night sweats. A past medical history of diabetes, hypertension, and neurological diseases is essential.</p>
        <p>Clinicians should ask the patients if any of the symptoms and signs are present, the level of functional disability in activities of daily living, onset, and progression.&#x000a0;Common signs and symptoms include abnormalities in gait, slurred speech, difficulty in walking, abnormal eye movements, difficulty swallowing, increased fatigue, incoordination in fine motor movements such as handwriting, buttoning shirts, typing, tremors, vertigo, and problems in cognition.<xref ref-type="bibr" rid="article-17936.r11">[11]</xref></p>
        <p>A general and neurological physical examination is an integral part of the evaluation. A complete neurological examination, including mental status, cranial nerves, and cerebellar examination, is critical. Grading and level of functional disability are assessable with the use of scoring systems such as the International Cooperative Ataxia Rating Scale, Brief Ataxia Rating Scale (BARS), and for patients with Friedrich's ataxia, the Friedreich's Ataxia Rating Scale.<xref ref-type="bibr" rid="article-17936.r12">[12]</xref><xref ref-type="bibr" rid="article-17936.r13">[13]</xref><xref ref-type="bibr" rid="article-17936.r14">[14]</xref></p>
      </sec>
      <sec id="article-17936.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The necessary tests are guided by clinical presentation and clinical suspicion.&#x000a0;Blood tests for specific deficiencies, drugs, and toxins may be in order. Urinalysis can look for mercury level measurement.</p>
        <p>Brain imaging includes a computed tomographic scan as an initial study, but magnetic resonance imaging (MRI) is critical to visualize structural lesions, strokes, and congenital or acquired abnormalities. Imaging of the spinal cord with MRI is indicated if a spine lesion is suspected.</p>
        <p>Genetic testing is the diagnostic course for inherited ataxias.</p>
      </sec>
      <sec id="article-17936.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Currently, there is no curative treatment available for hereditary ataxia.&#x000a0; Depending on the causes, if the ataxia results from a stroke, toxic substances, hypothyroidism, or any modifiable risk factors, treatment is targeted at the specific condition causing ataxia. Some treatable causes are reversible by medication such as vitamin E, coenzyme Q10 deficiencies, and episodic ataxia type two.<xref ref-type="bibr" rid="article-17936.r15">[15]</xref></p>
        <p>Patients may use devices to reduce functional disability, such as walking aids, canes, wheelchairs, and walkers. Patients can receive physical, speech therapy, and symptomatic treatment. Medications can reduce tremors, muscle stiffness, and sleeping disorders. There is evidence that physical and mental exercises can improve the lives of patients with ataxia.</p>
      </sec>
      <sec id="article-17936.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Alcohol use</p>
          </list-item>
          <list-item>
            <p>Ischemic stroke</p>
          </list-item>
          <list-item>
            <p>Cerebellar hemorrhage</p>
          </list-item>
          <list-item>
            <p>Drug-induced</p>
          </list-item>
          <list-item>
            <p>Toxicity</p>
          </list-item>
          <list-item>
            <p>Hypoxia or heat stroke</p>
          </list-item>
          <list-item>
            <p>Von Hippel-Lindau syndrome</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17936.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis largely depends on the type and cause of ataxia. Patients with progressive ataxia may suffer from worsening symptoms over the years and require symptomatic treatment. Hereditary ataxia has a shorter life expectancy; however, some people live up to the fifth or sixth decade. Severe forms may lead to death in childhood or the early years.</p>
        <p>If the cause is acquired, for example, alcohol or drug-induced ataxia, the underlying cause needs to be treated, and triggering factors removed to improve prognosis.</p>
      </sec>
      <sec id="article-17936.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of ataxia are related to the type of ataxia. Commonly, patients have rigidity, dyspnea, breathing difficulty, and choking, which may also lead to death in severe cases. Patients may require assistance in ventilation, feeding tubes, and airway management. Patients who are unable to walk or require wheelchair assistance may develop pressure ulcers, infections, and thrombosis.</p>
        <p>Psychological and psychiatric illnesses, such as dementia and depression, are common and require therapy. Other complications include lightheadedness, spasticity, tremors, lethargy, generalized pain, blood pressure changes, bowel, bladder, and sexual dysfunction.</p>
      </sec>
      <sec id="article-17936.s12" sec-type="Postoperative and Rehabilitation Care">
        <title>Postoperative and Rehabilitation Care</title>
        <p>
<bold>Rehabilitation&#x000a0;</bold>
</p>
        <p>Rehabilitation for individuals&#x000a0;with ataxia&#x000a0;emphasizes&#x000a0;balance, core stability, and coordination exercises, leading to significant improvement compared to control groups. Postural retraining is important&#x000a0;due to ataxia-related imbalances&#x000a0;showing&#x000a0;promising results. However, additional studies are required&#x000a0;to assess the benefits of&#x000a0;different exercise modalities due to limited sample size and research quality in current literature.<xref ref-type="bibr" rid="article-17936.r16">[16]</xref><xref ref-type="bibr" rid="article-17936.r17">[17]</xref><xref ref-type="bibr" rid="article-17936.r18">[18]</xref><xref ref-type="bibr" rid="article-17936.r19">[19]</xref></p>
      </sec>
      <sec id="article-17936.s13" sec-type="Consultations">
        <title>Consultations</title>
        <list list-type="bullet">
          <list-item>
            <p>Neurologist</p>
          </list-item>
          <list-item>
            <p>Social worker</p>
          </list-item>
          <list-item>
            <p>Physical therapy and rehabilitation</p>
          </list-item>
          <list-item>
            <p>Speech therapy</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17936.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients with ataxia may have a functional disability, so it is essential to inform them about the symptoms that should receive medical attention and provide them with assistance.</p>
        <p>Referrals should manage swallowing, speech, visual, and hearing difficulties to the respected departments, and patients should receive education on the prevention of common emergencies such as aspiration and falls.</p>
        <p>For&#x000a0;acquired etiologies that can be modified, such as alcohol or drug-induced ataxia, the underlying cause will require treatment.</p>
      </sec>
      <sec id="article-17936.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Ataxia frequently leads to complex decision making due to the multiple causes and nonspecific signs and symptoms. History taking and examination are essential in finding the cause and determining the severity of the illness. Neurologists, nurses, pediatricians, internal medicine physicians, occupational therapists, physiotherapists, radiologists, and pharmacists form a vital team for patient care. Each of them has a set role in the treatment and management of patients with ataxia.&#x000a0;The collaboration of the team with shared decision-making and communication improves patients outcome.</p>
        <p>As there is no determined treatment for ataxia, patients must receive assistance in reducing their functional disability by providing medications for symptoms, counseling, support groups, and wheelchair assistance. Research is underway to&#x000a0;improve treatment further and help improve the prognosis of patients.<xref ref-type="bibr" rid="article-17936.r20">[20]</xref><xref ref-type="bibr" rid="article-17936.r21">[21]</xref></p>
      </sec>
      <sec id="article-17936.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17936&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17936">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/neurology/ataxia-ataxia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=17936">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17936/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17936">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-17936.s17">
        <title>References</title>
        <ref id="article-17936.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mariotti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fancellu</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Di Donato</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>An overview of the patient with ataxia.</article-title>
            <source>J Neurol</source>
            <year>2005</year>
            <month>May</month>
            <volume>252</volume>
            <issue>5</issue>
            <fpage>511</fpage>
            <page-range>511-8</page-range>
            <pub-id pub-id-type="pmid">15895274</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17936.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Klockgether</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>[Ataxias. Diagnostic procedure and treatment].</article-title>
            <source>Nervenarzt</source>
            <year>2005</year>
            <month>Oct</month>
            <volume>76</volume>
            <issue>10</issue>
            <fpage>1275</fpage>
            <page-range>1275-83; quiz 1284-5</page-range>
            <pub-id pub-id-type="pmid">16175415</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17936.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Silver</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mercimek-Andrews</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Inherited Metabolic Disorders Presenting with Ataxia.</article-title>
            <source>Int J Mol Sci</source>
            <year>2020</year>
            <month>Aug</month>
            <day>01</day>
            <volume>21</volume>
            <issue>15</issue>
            <pub-id pub-id-type="pmid">32752260</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17936.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Muzaimi</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Palmer-Smith</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rosser</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Harper</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Wiles</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Ravine</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Robertson</surname>
                <given-names>NP</given-names>
              </name>
            </person-group>
            <article-title>Population based study of late onset cerebellar ataxia in south east Wales.</article-title>
            <source>J Neurol Neurosurg Psychiatry</source>
            <year>2004</year>
            <month>Aug</month>
            <volume>75</volume>
            <issue>8</issue>
            <fpage>1129</fpage>
            <page-range>1129-34</page-range>
            <pub-id pub-id-type="pmid">15258214</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17936.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salman</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of Cerebellar Diseases and Therapeutic Approaches.</article-title>
            <source>Cerebellum</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>4</fpage>
            <page-range>4-11</page-range>
            <pub-id pub-id-type="pmid">28940047</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17936.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Musselman</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Stoyanov</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Marasigan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jenkins</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Konczak</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Morton</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Bastian</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of ataxia in children: a systematic review.</article-title>
            <source>Neurology</source>
            <year>2014</year>
            <month>Jan</month>
            <day>07</day>
            <volume>82</volume>
            <issue>1</issue>
            <fpage>80</fpage>
            <page-range>80-9</page-range>
            <pub-id pub-id-type="pmid">24285620</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17936.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ruano</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Melo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Silva</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Coutinho</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies.</article-title>
            <source>Neuroepidemiology</source>
            <year>2014</year>
            <volume>42</volume>
            <issue>3</issue>
            <fpage>174</fpage>
            <page-range>174-83</page-range>
            <pub-id pub-id-type="pmid">24603320</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17936.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scott</surname>
                <given-names>SSO</given-names>
              </name>
              <name>
                <surname>Pedroso</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Barsottini</surname>
                <given-names>OGP</given-names>
              </name>
              <name>
                <surname>Fran&#x000e7;a-Junior</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Braga-Neto</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Natural history and epidemiology of the spinocerebellar ataxias: Insights from the first description to nowadays.</article-title>
            <source>J Neurol Sci</source>
            <year>2020</year>
            <month>Oct</month>
            <day>15</day>
            <volume>417</volume>
            <fpage>117082</fpage>
            <pub-id pub-id-type="pmid">32791425</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17936.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pandolfo</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Friedreich ataxia.</article-title>
            <source>Arch Neurol</source>
            <year>2008</year>
            <month>Oct</month>
            <volume>65</volume>
            <issue>10</issue>
            <fpage>1296</fpage>
            <page-range>1296-303</page-range>
            <pub-id pub-id-type="pmid">18852343</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17936.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bastian</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms of ataxia.</article-title>
            <source>Phys Ther</source>
            <year>1997</year>
            <month>Jun</month>
            <volume>77</volume>
            <issue>6</issue>
            <fpage>672</fpage>
            <page-range>672-5</page-range>
            <pub-id pub-id-type="pmid">9184691</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17936.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ashizawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Xia</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Ataxia.</article-title>
            <source>Continuum (Minneap Minn)</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>22</volume>
            <issue>4 Movement Disorders</issue>
            <fpage>1208</fpage>
            <page-range>1208-26</page-range>
            <pub-id pub-id-type="pmid">27495205</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17936.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Trouillas</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Takayanagi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hallett</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Currier</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Subramony</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Wessel</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bryer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Diener</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Massaquoi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gomez</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Coutinho</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ben Hamida</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Campanella</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Filla</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schut</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Timann</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Honnorat</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nighoghossian</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Manyam</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology.</article-title>
            <source>J Neurol Sci</source>
            <year>1997</year>
            <month>Feb</month>
            <day>12</day>
            <volume>145</volume>
            <issue>2</issue>
            <fpage>205</fpage>
            <page-range>205-11</page-range>
            <pub-id pub-id-type="pmid">9094050</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17936.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schmahmann</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Gardner</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>MacMore</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Vangel</surname>
                <given-names>MG</given-names>
              </name>
            </person-group>
            <article-title>Development of a brief ataxia rating scale (BARS) based on a modified form of the ICARS.</article-title>
            <source>Mov Disord</source>
            <year>2009</year>
            <month>Sep</month>
            <day>15</day>
            <volume>24</volume>
            <issue>12</issue>
            <fpage>1820</fpage>
            <page-range>1820-8</page-range>
            <pub-id pub-id-type="pmid">19562773</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17936.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Subramony</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>May</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Lynch</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gomez</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fischbeck</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hallett</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ashizawa</surname>
                <given-names>T</given-names>
              </name>
              <collab>Cooperative Ataxia Group</collab>
            </person-group>
            <article-title>Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale.</article-title>
            <source>Neurology</source>
            <year>2005</year>
            <month>Apr</month>
            <day>12</day>
            <volume>64</volume>
            <issue>7</issue>
            <fpage>1261</fpage>
            <page-range>1261-2</page-range>
            <pub-id pub-id-type="pmid">15824358</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17936.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kwei</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Kuo</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>An Overview of the Current State and the Future of Ataxia Treatments.</article-title>
            <source>Neurol Clin</source>
            <year>2020</year>
            <month>May</month>
            <volume>38</volume>
            <issue>2</issue>
            <fpage>449</fpage>
            <page-range>449-467</page-range>
            <pub-id pub-id-type="pmid">32279720</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17936.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miyai</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hattori</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mihara</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hatakenaka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yagura</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sobue</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Nishizawa</surname>
                <given-names>M</given-names>
              </name>
              <collab>Cerebellar Ataxia Rehabilitation Trialists Collaboration</collab>
            </person-group>
            <article-title>Cerebellar ataxia rehabilitation trial in degenerative cerebellar diseases.</article-title>
            <source>Neurorehabil Neural Repair</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>26</volume>
            <issue>5</issue>
            <fpage>515</fpage>
            <page-range>515-22</page-range>
            <pub-id pub-id-type="pmid">22140200</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17936.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuo</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>Ataxia.</article-title>
            <source>Continuum (Minneap Minn)</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>25</volume>
            <issue>4</issue>
            <fpage>1036</fpage>
            <page-range>1036-1054</page-range>
            <pub-id pub-id-type="pmid">31356292</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17936.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elshafey</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Abdrabo</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Elnaggar</surname>
                <given-names>RK</given-names>
              </name>
            </person-group>
            <article-title>Effects of a core stability exercise program on balance and coordination in children with cerebellar ataxic cerebral palsy.</article-title>
            <source>J Musculoskelet Neuronal Interact</source>
            <year>2022</year>
            <month>Jun</month>
            <day>01</day>
            <volume>22</volume>
            <issue>2</issue>
            <fpage>172</fpage>
            <page-range>172-178</page-range>
            <pub-id pub-id-type="pmid">35642697</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17936.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marquer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Barbieri</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rennou</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>The assessment and treatment of postural disorders in cerebellar ataxia: a systematic review.</article-title>
            <source>Ann Phys Rehabil Med</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>57</volume>
            <issue>2</issue>
            <fpage>67</fpage>
            <page-range>67-78</page-range>
            <pub-id pub-id-type="pmid">24582474</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17936.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amirifar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ranjouri</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Lavin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Abolhassani</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yazdani</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Aghamohammadi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Ataxia-telangiectasia: epidemiology, pathogenesis, clinical phenotype, diagnosis, prognosis and management.</article-title>
            <source>Expert Rev Clin Immunol</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>16</volume>
            <issue>9</issue>
            <fpage>859</fpage>
            <page-range>859-871</page-range>
            <pub-id pub-id-type="pmid">32791865</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17936.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lallemant-Dudek</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Durr</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Clinical and genetic update of hereditary spastic paraparesis.</article-title>
            <source>Rev Neurol (Paris)</source>
            <year>2021</year>
            <month>May</month>
            <volume>177</volume>
            <issue>5</issue>
            <fpage>550</fpage>
            <page-range>550-556</page-range>
            <pub-id pub-id-type="pmid">32807405</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
